Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide.
D000818:Animals; D003863:Depression / Q000139:chemically induced / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005998:Glycine / Q000494:pharmacology / Q000627:therapeutic use; D000882:Haplorhini; D006801:Humans; D007274:Injections, Intraperitoneal; D007930:Leucine / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009842:Oligopeptides / Q000494:pharmacology* / Q000627:therapeutic use; D010293:Pargyline / Q000494:pharmacology; D011392:Proline / Q000494:pharmacology / Q000627:therapeutic use; D012110:Reserpine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D046948:Secologanin Tryptamine Alkaloids / Q000037:antagonists & inhibitors*
D009842:Oligopeptides; D046948:Secologanin Tryptamine Alkaloids; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D011392:Proline; D010293:Pargyline; D007930:Leucine; D005998:Glycine